Chart 2. Studies analyzed according to Database/Journal, title, authors, methodological design, year of publication, country of origin of the study, 2022.
| Author/Title | Year Country |
Design/Sample | Objective/ Interventions | Outcomes | Level of Evidence |
|---|---|---|---|---|---|
| Carr, Rippey, Cooke(20)
“Factors associated with peripheral intravenous cannulation first time insertion success in the emergency department”. |
2019 Australia | Prospective observational 879 patients (n=1,201 PVC) |
To identify the incidence of factors associated with peripheral intravenous infusion and the success rate of first versus two or more punctures. | Incidence of first puncture success rate = 645/879. Success related to age and palpability of the patient’s vein, as well as practitioner’s confidence and experience. |
3.e |
| Sweeny et al.(21)
“The experience of patients at high risk of difficult peripheral intravenous cannulation: An Australian prospective observational study”. |
2022 Australia | Prospective observational n=1,084 |
To identify patients with difficult peripheral intravenous cannulation (DPIVC) | Patient characteristics (absence of visible or palpable vein, history of difficult PVC) type of PVC (larger caliber), site (hand and wrist) were pointed out as factors. |
3.e |
| Marsh et al.(22)
“Peripheral intravenous catheter non-infectious complications in adults: A systematic review and meta-analysis”. |
2020 Australia | Systematic review with 103 studies (n= 96,777 PVC) |
To point out main peripheral complications related to PVC use and where they were inserted. | Incidence of phlebitis (23.8%) and infiltration (13.7%) being significantly higher when catheters were inserted in the emergency department. |
1.b |
| Mihala et al.(23)
“Phlebitis signs and symptoms with peripheral intravenous catheters”. |
2018 Australia | Descriptive observational n=3,283 |
To calculate incidence of signs and symptoms for diagnosis of phlebitis and their correlations. | Considerably low incidence and only correlations observed were heat x stiffness, heat x swelling and heat x erythema. | 4.a |
| Marsh et al.(24)
“Devices and dressings to secure peripheral venous catheters: A Cochrane systematic review and meta-analysis”. |
2017 Australia | Systematic review with meta-analysis of 6 studies (n=1,539) | To evaluate the effects of fixation devices on the incidence of catheter loss. | Less PVC detachment with transparent dressing compared to gauze. |
1.a |
| Schmutz et al.(25)
“Dislodgement forces and cost effectiveness of dressings and securement for peripheral intravenous catheters: A randomized controlled trial”. |
2020 Germany | Randomized controlled trial n= 209 |
Force required to remove a PVC versus four dressing and fixation methods. | Sterile absorbent dressing covered by two incisive polyester wool elastics had higher strength and better cost-effectiveness compared to the other techniques. | 1.c |
| Rickard et al.(26)
“Dressings and securements for the prevention of peripheral intravenous catheter failure in adults (SAVE):a pragmatic, randomized controlled, trial”. |
2018 Australia | Randomized controlled trial n= 1,807 |
Effectiveness and costs of three types of standard borderless polyurethane dressing. | No significant results were observed. These methods are associated with loss of PVCs and low durability. |
1.c |
| Corley et al.(27)
“Peripheral intravenous catheter securement: An integrative review of contemporary literature around medical adhesive tapes and supplementary securement products”. |
2022 Australia | Integrative review with 19 studies n=43,683 PVC |
Synthesize the evidence related to medical adhesive tapes for PVCs. | The quality assessment identified high risk of bias or confounding factors. The authors concluded that the evidence is limited. |
4.b |
| Keogh et al.(28)
“Implementation and evaluation of short peripheral intravenous catheter flushing guidelines: a stepped wedge cluster randomized trial”. |
2020 Australia | Randomized controlled trial n= 619 |
Evaluated the impact of a multifaceted intervention for PVC maintenance. | lushing with 0.9% NaCL administered via an already prepared syringe with ready-to-use system showed a difference in risk (-8%, 95% CI -14 to -1, p = 0.032) compared to the control group with standard care. |
1.d |
| Marsh et al.(29)
“Securement methods for peripheral venous catheters to prevent failure: A randomized controlled pilot trial”. |
2015 Australia | Randomized controlled trial n=89 |
Evaluating the effectiveness of four safety methods to prevent PVC-related failures | Catheter failure was lowest in the tissue adhesive group (14%) and highest in the control group (38%). |
1.c |
| Marsh et al.(30)
“How many audits do you really need?: Learnings from 5-years of peripheral intravenous catheter audits”. |
2021 Australia | Prospective observational n=2,274 PVC |
Determine the optimal number of PVC patients for clinical audits. | Authors defined that optimal values should be between 100 and 250 PVC per audit round, depending on the prevalence of complication. |
3.e |
| Dutra et al.(31)
“Prevention of events with vascular catheters: Validation of an instrument”. |
2021 Brazil |
Methodological study n=50 |
To validate an instrument that identifies factors that hinder PVC insertion and maintenance. | Instrument proved to be valid (high Content Index) and reliable (through Interobserver reliability using Kappa coefficient). | 4.c |
| Yagnik, Graves, Thong(32). “Plastic in patient study: Prospective audit of adherence to peripheral intravenous cannula monitoring and documentation guidelines, with the aim of reducing future rates of intravenous cannula-related complications”. |
2017 Australia | Prospective observational n=102 |
To improve compliance of PVC documentation and monitoring through three “The plastic in patient - PIP” interventions. | Documentation improved in the post-intervention group (36.4 x 50%, p = 0.025). Early identification for non-indication of PVC and a trend towards a reduction in PVC-related phlebitis also had positive results post-intervention. |
3.c |
| Webster et al.(33)
“Clinically indicated replacement versus routine replacement of peripheral venous catheters”. |
2019 Australia | Systematic review with meta-analysis of 9 studies (n = 7,412) |
To evaluate the effects of PVC removal when clinically indicated versus routine catheter removal. | There is no clear difference in the rates of catheter-related infection, phlebitis and pain in the two groups. There is moderate-certainty evidence that catheter infiltration and blockage are lower when access is changed routinely. With moderate certainty evidence, there was a reduction in device-related costs when clinically indicated. |
1.a |
| Ray-Barruel et al.(34)
“The I-DECIDED clinical decision-making tool for peripheral intravenous catheter assessment and safe removal: a clinimetric evaluation”. |
2020 Australia | Methodological study n=68 |
To validate an 8-step tool for device assessment and decision making. | “I-DECIDED” tool demonstrated strong content validity, with high reliability and replicability for advising PVC-related decision making and assistance. |
4.c |
PVC - Peripheral venous catheter; PVP - Peripheral venous puncture.